Galcanezumab-Gnlm 00002-1436
Product NDC
00002-1436- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- September 27, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Galcanezumab | 120 mg/mL |
Packaging Options(1)
1 mL in 1 SYRINGE (0002-1436-00)